Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Trends in brachytherapy utilization in Canada from 2011 to 2020.

Physics and imaging in radiation oncology·2026
Same author

B-cell precursor acute lymphoblastic leukaemia with <i>IGH::CEBP</i> rearrangement: what have we learnt over the years?

Haematologica·2026
Same author

Evaluating the Role of VELscope in Oral Cancer and Pre-Cancer Screening: A Scoping Review.

Asian Pacific journal of cancer prevention : APJCP·2026
Same author

Towards robust deep learning-based autosegmentation in MRI-planned gynecological brachytherapy: Importance of scalable development and comprehensive evaluation.

Brachytherapy·2026
Same author

Benchmarking the paediatric T-cell ALL subtype classifier, TALLSorts.

British journal of haematology·2025
Same author

Neonatal unit human resources: coverage for six cadres and trends for staff-to-baby ratios in 65 neonatal units implementing with NEST360 in Kenya, Malawi, Nigeria, and Tanzania.

Human resources for health·2025
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: May 24, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

バーキットのリンパ腫

Elizabeth M Molyneux1, Rosemary Rochford, Beverly Griffin

  • 1College Of Medicine, Blantyre, Malawi. emolyneux@malawi.net

Lancet (London, England)
|February 16, 2012
PubMed
まとめ
この要約は機械生成です。

ブルキットリンパ腫は,急速に成長する癌であり,エプスタイン・バーウイルスとc-MYC腫瘍遺伝子の活性化に関連しています. 治療の成功は年齢や場所によって異なるが,リトゥキシマブのような将来的な治療法が有望である.

さらに関連する動画

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

関連する実験動画

Last Updated: May 24, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

科学分野:

  • 腫瘍学 腫瘍学
  • 血液学 ヘマトロジ
  • ウイルス学 ウイルス学 ウイルス学

背景:

  • バーキットリンパ腫は,急激な腫瘍成長が特徴である攻撃的なB細胞非ホジキンリンパ腫です.
  • これは,エプスタイン・バーウイルスと,c-MYC腫瘍遺伝子を活性化する染色体転位と関連しています.
  • このリンパ腫は,マラリアが流行している地域で最も一般的な小児がんであり,HIVに感染した個体でも流行しています.

研究 の 目的:

  • バーキットリンパ腫の特徴,関連性,治療結果を見直す.
  • 患者の年齢と地理的位置に基づいて治療と結果の格差を強調する.
  • モノクローナル抗体治療を含む治療における潜在的な進歩を探求する.

主な方法:

  • バーキットリンパ腫の疫学,病原性,および臨床管理に関する文献レビュー.
  • 異なる患者集団 (子供対成人) と医療環境 (低所得対高所得国) での治療結果の分析.
  • リトゥキシマブなどの新興治療戦略の評価.

主要な成果:

  • ブルキットリンパ腫のアウトカムは,集中化学療法を受けた子供では優秀ですが,高齢者の場合は不良です.
  • 治療の強度と成功率は,低所得国と高所得国の間で大きく異なります.
  • リトキシマブは,治療結果を改善し,毒性を減らす可能性を示しています.

結論:

  • Burkittのリンパ腫の管理には,集中的な化学療法と強力なサポートケアが必要です.
  • 年齢や社会経済的要因は,治療の成功に重大な影響を及ぼします.
  • モノクローナル抗体療法は,患者の予後を改善するための有望な将来の方向性を示しています.